<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim YJ</submitter><funding>Korea Institute for Advancement of Technology</funding><funding>National Research Foundation of Korea</funding><pagination>29535-29542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9562052</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(45)</volume><pubmed_abstract>Herein, we report a sensitive and selective enzyme-linked aptamer-based sandwich assay (ELASA) to detect &lt;i>Plasmodium falciparum&lt;/i> lactate dehydrogenase (&lt;i>Pf&lt;/i>LDH), which is an attractive biomarker for malaria diagnosis and antimalarial medication. We performed the sandwich assay with a single aptamer sequence, called 2008s, owing to the structural properties of the &lt;i>Pf&lt;/i>LDH tetramer instead of using a conventional sandwich assay with two different aptamers (or antibodies) for capturing and probing a target molecule. First, the biotinylated &lt;i>Pf&lt;/i>LDH aptamer was linked with immobilized streptavidin on a microwell plate for binding flexibility, and then &lt;i>Pf&lt;/i>LDH was bound to the aptamer. Next, a horseradish peroxidase-conjugated aptamer of the same sequence was used to analyze &lt;i>Pf&lt;/i>LDH quantitatively. Using this approach, the limit of detection (LOD) of &lt;i>Pf&lt;/i>LDH with the naked eye was 100 ng mL&lt;sup>-1&lt;/sup>, and the LOD and limit of quantification from the absorbance measurements were 34.9 ng mL&lt;sup>-1&lt;/sup> and 95.5 ng mL&lt;sup>-1&lt;/sup>, respectively, based on &lt;i>Pf&lt;/i>LDH spiked blood samples. Our proposed method selectively binds &lt;i>Pf&lt;/i>LDH, not human lactate dehydrogenase. Therefore, this method may be a valuable tool for diagnosing, monitoring, and quarantining malaria cases easily and rapidly.</pubmed_abstract><journal>RSC advances</journal><pubmed_title>Enzyme-linked aptamer-based sandwich assay (ELASA) for detecting &lt;i>Plasmodium falciparum&lt;/i> lactate dehydrogenase, a malarial biomarker.</pubmed_title><pmcid>PMC9562052</pmcid><funding_grant_id>2021R1F1A1062994</funding_grant_id><funding_grant_id>P0017805</funding_grant_id><funding_grant_id>2021RIS-001</funding_grant_id><pubmed_authors>Kim YJ</pubmed_authors><pubmed_authors>Choi JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enzyme-linked aptamer-based sandwich assay (ELASA) for detecting &lt;i>Plasmodium falciparum&lt;/i> lactate dehydrogenase, a malarial biomarker.</name><description>Herein, we report a sensitive and selective enzyme-linked aptamer-based sandwich assay (ELASA) to detect &lt;i>Plasmodium falciparum&lt;/i> lactate dehydrogenase (&lt;i>Pf&lt;/i>LDH), which is an attractive biomarker for malaria diagnosis and antimalarial medication. We performed the sandwich assay with a single aptamer sequence, called 2008s, owing to the structural properties of the &lt;i>Pf&lt;/i>LDH tetramer instead of using a conventional sandwich assay with two different aptamers (or antibodies) for capturing and probing a target molecule. First, the biotinylated &lt;i>Pf&lt;/i>LDH aptamer was linked with immobilized streptavidin on a microwell plate for binding flexibility, and then &lt;i>Pf&lt;/i>LDH was bound to the aptamer. Next, a horseradish peroxidase-conjugated aptamer of the same sequence was used to analyze &lt;i>Pf&lt;/i>LDH quantitatively. Using this approach, the limit of detection (LOD) of &lt;i>Pf&lt;/i>LDH with the naked eye was 100 ng mL&lt;sup>-1&lt;/sup>, and the LOD and limit of quantification from the absorbance measurements were 34.9 ng mL&lt;sup>-1&lt;/sup> and 95.5 ng mL&lt;sup>-1&lt;/sup>, respectively, based on &lt;i>Pf&lt;/i>LDH spiked blood samples. Our proposed method selectively binds &lt;i>Pf&lt;/i>LDH, not human lactate dehydrogenase. Therefore, this method may be a valuable tool for diagnosing, monitoring, and quarantining malaria cases easily and rapidly.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-05T14:54:35.471Z</modification><creation>2025-04-05T14:54:35.471Z</creation></dates><accession>S-EPMC9562052</accession><cross_references><pubmed>36320752</pubmed><doi>10.1039/d2ra03796c</doi></cross_references></HashMap>